Luminespib
Luminespib (INN,[1] previously known as NVP-AUY922) is an experimental drug candidate for the treatment of cancer. It was discovered through a collaboration between The Institute of Cancer Research and the pharmaceutical company Vernalis[2] and licensed to Novartis.[3] From 2011 to 2014 it was in Phase II clinical trials.[4][5] Chemically it is a resorcinylic isoxazole amide[5]
Luminespib is an inhibitor of heat shock protein 90 (Hsp90),[6] which is a chaperone protein that plays a role in the modification of a variety of proteins that have been implicated in oncogenesis. Luminespib has shown promising activity in preclinical testing against several different tumor types.[7][8][9][10]
A related compound, NVP-HSP990, was abandoned by Novartis in 2012 after it failed to show efficacy in an early clinical trial.[5]
See also[edit | edit source]
References[edit | edit source]
- ↑ "WHO Drug Information. International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 70" (PDF). World Health Organization. pp. 297–8. Retrieved 16 July 2016.
- ↑ "Structure-based design of cancer therapeutics" (PDF). The Institute of Cancer Research.
- ↑ "AUY922". Vernalis. Archived from the original on 2011-09-29.
{{cite web}}
: Unknown parameter|deadurl=
ignored (help) - ↑ "Small caps: Vernalis drug fillip". Financial Times. July 19, 2011.
{{cite web}}
: Italic or bold markup not allowed in:|publisher=
(help) - ↑ 5.0 5.1 5.2
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedBrough
- ↑
- ↑
- ↑
- ↑
Luminespib Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD